Gluconic Acid

Gluconic Acid

SCHEMBL861904

O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A

The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.73
LMNA P02545 2/20 0.52
USP2 O75604 1/20 0.47
SLCO1B1 Q9Y6L6 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
TSHR P16473 2/20 0.41
CYP2C9 P11712 1/20 0.41
OR51E2 Q9H255 1/20 0.33
AKR1B1 P15121 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KDM4E B2RXH2 2/20 0.32
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glucuronic Acid SCHEMBL3686871 1.00 PDE4A (0.73) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL14841816 1.00 PDE4A (0.73) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Glucuronic Acid SCHEMBL8675875 1.00 PDE4A (0.73) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Glucuronic Acid SCHEMBL2365643 1.00 PDE4A (0.73) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL20741140 1.00 PDE4A (0.73) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL2785483 1.00 PDE4A (0.73) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Glucuronic Acid SCHEMBL10823159 1.00 PDE4A (0.73) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL4389427 1.00 PDE4A (0.73) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL20815121 1.00 PDE4A (0.73) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Glucuronic Acid SCHEMBL7089004 1.00 PDE4A (0.73) PDE4ALMNAUSP2SLCO1B1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4680759-A2 METHOD FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING L-PSICOSE Annikki GmbH (AT) 2026-01-21 EP disclosed
EP-4680760-A2 METHOD FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING D-PSICOSE Annikki GmbH (AT) 2026-01-21 EP disclosed
EP-4520839-A2 PROCESS FOR PREPARING AN AQUEOUS SOLUTION CONTAINING D-PSICOSE Annikki GmbH (AT) 2025-03-12 EP disclosed
EP-4446422-A2 PROCESS FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING L-PSICOSE Annikki GmbH (AT) 2024-10-16 EP disclosed
WO-2024189215-A2 METHOD FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING D-PSICOSE ANNIKKI GMBH (AT) 2024-09-19 WO disclosed
CN-116948925-A Construction and application of gluconobacter oxydans capable of efficiently synthesizing 2-KLG by utilizing glucose 江南大学 2023-10-27 CN disclosed
CN-114767613-A Novel microorganism belonging to family Hyphomycetaceae and use thereof 科丝美诗株式会社 2022-07-22 CN disclosed
EP-3548473-A1 HMF PRODUCTION METHOD Südzucker AG (DE) 2019-10-09 EP disclosed
EP-3472291-A1 CONCENTRATED ISOTROPIC LIQUID DETERGENTS CONTAINING POLYMERS Henkel AG & Co. KGaA (DE) 2019-04-24 EP disclosed
EP-3472290-A1 CONCENTRATED ISOTROPIC LIQUID DETERGENTS CONTAINING POLYMERS Henkel AG & Co. KGaA (DE) 2019-04-24 EP disclosed
WO-2007045251-A2 A COMPOSITION COMPRISING A COUPLED ENZYME SYSTEM DANISCO A/S (DK) 2007-04-26 WO disclosed
WO-2006065840-A2 PROCESS FOR THE SYNTHESIS OF (S)-1-(3,5-BIS(TRIFLUOROMETHYL)-PHENYL)ETHAN-1-OL MERCK & CO., INC. (US) 2006-06-22 WO disclosed
CN-1643206-A Antimicrobial yarn with nanosilver particles and method of producing the same CC TECHNOLOGY INVEST CO LTD (HK) 2005-07-20 CN disclosed
EP-1490543-A2 ANTIMICROBIAL YARN HAVING NANOSILVER PARTICLES AND METHODS FOR MANUFACTURING THE SAME CC Technology Investment Co., Ltd (CN) 2004-12-29 EP disclosed
CN-1133426-C Novel stable preparation use paracetamol as base and method for preparing same SCR�������չ�˾ 2004-01-07 CN disclosed
WO-2003080911-A2 ANTIMICROBIAL YARN HAVING NANOSILVER PARTICLES AND METHODS FOR MANUFACTURING THE SAME CC TECHNOLOGY INVESTMENT CO., LTD (CN) 2003-10-02 WO disclosed
EP-1126781-A1 METHOD AND APPARATUS FOR SIGNAL TRANSMISSION AND DETECTION USING A CONTACT DEVICE Abreu, Marcio Marc Aurelio Martins (US) 2001-08-29 EP disclosed
WO-2000025662-A9 METHOD AND APPARATUS FOR SIGNAL TRANSMISSION AND DETECTION USING A CONTACT DEVICE ABREU MARCIO MARC AURELIO MART (US) 2000-09-21 WO disclosed
WO-2000025662-A1 METHOD AND APPARATUS FOR SIGNAL TRANSMISSION AND DETECTION USING A CONTACT DEVICE ABREU MARCIO MARC AURELIO MART (US) 2000-05-11 WO disclosed
CN-1204960-A Novel stable preparation use paracetamol as base and method for preparing same SCR PHARMATOP (FR) 1999-01-13 CN disclosed